Intravenous dexamethasone versus oral glycerol versus placebo in reducing auditory sequelae of childhood bacterial meningitis
Completed
- Conditions
- Bacterial meningitisNervous System DiseasesInflammatory diseases of the central nervous system
- Registration Number
- ISRCTN35932399
- Lead Sponsor
- Alfred Kordelin Fund (Finland)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 704
Inclusion Criteria
Children at age two months to 16 years in whom bacterial meningitis was diagnosed and treated in the Institutions
Exclusion Criteria
1. Recent head injury
2. Previous neurosurgery
3. Neurological diseases
4. Immunosuppression
5. Known hearing impairment
6. More than one dose of parenteral anti-microbial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method